or Try an Advanced Search...

    Technical Analysis for NUVB - Nuvation Bio Inc.

    Grade Last Price % Change Price Change
    F 2.30 4.07% 0.09
    NUVB closed up 4.07 percent on Friday, November 1, 2024, on 1.39 times normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NUVB trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 4.07%
    Earnings Movers Other 4.07%
    Shooting Star Candlestick Bearish -1.71%
    20 DMA Support Bullish -1.71%
    Doji - Bearish? Reversal -1.71%
    NR7 Range Contraction -2.54%
    Narrow Range Bar Range Contraction -2.54%
    Older End-of-Day Signals for NUVB ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 20 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    20 DMA Resistance about 22 hours ago
    10 DMA Resistance about 22 hours ago
    Up 3% about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NUVB Chart by TradingView
    Basic chart:

    Profile

    Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Prostate Cancer

    Is NUVB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market
    Oct 16 Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?
    Oct 16 Robert Mashal At Nuvation Bio Tops Up Holding By US$220k
    Oct 14 Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?
    Oct 9 Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35
    Oct 7 Nuvation Bio names Philippe Sauvage CFO
    Oct 7 Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
    Oct 2 Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System
    Sep 14 Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
    Sep 9 Nuvation Bio to Present at the Cantor Global Healthcare Conference
    See more NUVB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.1598
    52 Week Low 1.21
    Average Volume 1,554,760
    200-Day Moving Average 2.71
    50-Day Moving Average 2.62
    20-Day Moving Average 2.31
    10-Day Moving Average 2.32
    Average True Range 0.16
    RSI (14) 45.65
    ADX 19.76
    +DI 18.88
    -DI 21.49
    Chandelier Exit (Long, 3 ATRs) 2.11
    Chandelier Exit (Short, 3 ATRs) 2.49
    Upper Bollinger Bands 2.55
    Lower Bollinger Band 2.07
    Percent B (%b) 0.48
    BandWidth 20.52
    MACD Line -0.07
    MACD Signal Line -0.09
    MACD Histogram 0.0142
    Fundamentals Value
    Market Cap 501.27 Million
    Num Shares 218 Million
    EPS -0.37
    Price-to-Earnings (P/E) Ratio -6.22
    Price-to-Sales 0.00
    Price-to-Book 0.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.45
    Resistance 3 (R3) 2.44 2.38 2.43
    Resistance 2 (R2) 2.38 2.34 2.38 2.42
    Resistance 1 (R1) 2.34 2.31 2.36 2.35 2.41
    Pivot Point 2.28 2.28 2.29 2.28 2.28
    Support 1 (S1) 2.24 2.24 2.26 2.25 2.19
    Support 2 (S2) 2.18 2.21 2.18 2.18
    Support 3 (S3) 2.14 2.18 2.18
    Support 4 (S4) 2.15